Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alpine Immune Sciences Inc (NASDAQ:ALPN)

11.85
Delayed Data
As of Oct 19
 +0.05 / +0.42%
Today’s Change
7.20
Today|||52-Week Range
31.08
+32.25%
Year-to-Date
No recent news for Alpine Immune Sciences Inc.

Today’s Trading

Previous close11.80
Today’s open11.13
Day’s range11.07 - 11.85
Volume6,770
Average volume (3 months)32,261
Market cap$164.5M
Dividend yield--
Data as of 10/19/2017

Growth & Valuation

Earnings growth (last year)+16.42%
Earnings growth (this year)+74.75%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.83

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...0.000.00%
CLBSCaladrius Bioscience...+0.03+0.88%
MTEMMolecular Templates ...-0.35-3.62%
CSBRChampions Oncology I...+0.08+2.50%
Data as of 10/19/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$0.00
Annual profit (last year)-$31.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Mitchell H. Gold
President &
Director
Jay Venkatesan
Corporate headquarters
Seattle, Washington

Forecasts